Higher rates of certain cancers in countries, such as the UK, may be linked to two particular strains of bacteria.
Q&A: Atsena Therapeutics’ gene therapy for inherited blindness shows promise
Seven years after the FDA approved Luxterna, scientists have yet to bring another congenital blindness treatment to the market. A team of researchers from the